Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Failure, Chronic | 7 | 2021 | 952 | 1.650 |
Why?
|
| Kidney Transplantation | 10 | 2021 | 571 | 1.640 |
Why?
|
| Renal Dialysis | 8 | 2015 | 947 | 1.180 |
Why?
|
| Catheters, Indwelling | 4 | 2012 | 157 | 0.830 |
Why?
|
| Waiting Lists | 1 | 2021 | 237 | 0.610 |
Why?
|
| Perioperative Care | 1 | 2021 | 212 | 0.590 |
Why?
|
| Health Policy | 1 | 2021 | 232 | 0.580 |
Why?
|
| Graft Survival | 2 | 2018 | 473 | 0.550 |
Why?
|
| Tissue and Organ Procurement | 1 | 2021 | 246 | 0.550 |
Why?
|
| Bacteremia | 3 | 2012 | 428 | 0.530 |
Why?
|
| Biofilms | 3 | 2012 | 98 | 0.510 |
Why?
|
| Cause of Death | 1 | 2018 | 509 | 0.500 |
Why?
|
| Acute Kidney Injury | 4 | 2021 | 670 | 0.450 |
Why?
|
| Kidney | 2 | 2015 | 1338 | 0.430 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 211 | 0.410 |
Why?
|
| Glomerular Filtration Rate | 2 | 2018 | 573 | 0.400 |
Why?
|
| Cerebral Angiography | 1 | 2013 | 107 | 0.390 |
Why?
|
| Brain Edema | 1 | 2013 | 70 | 0.390 |
Why?
|
| Equipment Contamination | 3 | 2007 | 41 | 0.380 |
Why?
|
| Medicare | 1 | 2015 | 447 | 0.360 |
Why?
|
| Carotid Artery Diseases | 1 | 2013 | 137 | 0.360 |
Why?
|
| Aneurysm, False | 1 | 2013 | 93 | 0.360 |
Why?
|
| Catheterization | 3 | 2008 | 241 | 0.360 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2015 | 694 | 0.350 |
Why?
|
| Diabetic Nephropathies | 2 | 2018 | 115 | 0.350 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 137 | 0.340 |
Why?
|
| Anti-Bacterial Agents | 4 | 2012 | 2552 | 0.340 |
Why?
|
| Prosthesis-Related Infections | 1 | 2012 | 187 | 0.320 |
Why?
|
| Bacterial Infections | 1 | 2012 | 323 | 0.310 |
Why?
|
| Contrast Media | 1 | 2013 | 507 | 0.310 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 767 | 0.300 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2007 | 149 | 0.300 |
Why?
|
| Pyelonephritis | 1 | 2006 | 29 | 0.240 |
Why?
|
| Hip Fractures | 2 | 2017 | 71 | 0.240 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2087 | 0.240 |
Why?
|
| Pancreas Transplantation | 2 | 2005 | 31 | 0.240 |
Why?
|
| Ceftriaxone | 1 | 2006 | 69 | 0.240 |
Why?
|
| Middle Aged | 18 | 2018 | 29021 | 0.230 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2005 | 9 | 0.230 |
Why?
|
| Emphysema | 1 | 2006 | 67 | 0.230 |
Why?
|
| Lipectomy | 1 | 2005 | 9 | 0.230 |
Why?
|
| Nephrotic Syndrome | 1 | 2005 | 51 | 0.230 |
Why?
|
| Proteinuria | 1 | 2005 | 111 | 0.220 |
Why?
|
| Endocarditis, Bacterial | 1 | 2006 | 137 | 0.220 |
Why?
|
| Diabetic Angiopathies | 1 | 2005 | 72 | 0.220 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2004 | 11 | 0.220 |
Why?
|
| Castleman Disease | 1 | 2004 | 16 | 0.220 |
Why?
|
| Health Care Costs | 1 | 2007 | 415 | 0.210 |
Why?
|
| HIV Seropositivity | 1 | 2004 | 128 | 0.200 |
Why?
|
| Preoperative Care | 1 | 2005 | 368 | 0.200 |
Why?
|
| Male | 21 | 2021 | 65014 | 0.190 |
Why?
|
| Multiple Myeloma | 1 | 2005 | 202 | 0.190 |
Why?
|
| Cryptococcus neoformans | 1 | 2002 | 23 | 0.190 |
Why?
|
| Cryptococcosis | 1 | 2002 | 45 | 0.180 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2006 | 425 | 0.180 |
Why?
|
| Pleural Effusion | 1 | 2002 | 110 | 0.170 |
Why?
|
| Humans | 26 | 2021 | 132247 | 0.170 |
Why?
|
| Health Care Rationing | 1 | 2021 | 63 | 0.170 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 158 | 0.160 |
Why?
|
| Europe | 1 | 2021 | 373 | 0.160 |
Why?
|
| United States | 6 | 2021 | 11669 | 0.160 |
Why?
|
| Adult | 12 | 2018 | 31614 | 0.160 |
Why?
|
| Mass Screening | 1 | 2005 | 830 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2018 | 846 | 0.150 |
Why?
|
| Organ Transplantation | 1 | 2021 | 180 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 893 | 0.140 |
Why?
|
| Intensive Care Units | 1 | 2021 | 524 | 0.140 |
Why?
|
| Aged | 7 | 2018 | 21482 | 0.140 |
Why?
|
| Abatacept | 1 | 2017 | 27 | 0.140 |
Why?
|
| Minocycline | 2 | 2008 | 42 | 0.140 |
Why?
|
| Antilymphocyte Serum | 1 | 2017 | 42 | 0.140 |
Why?
|
| Immunosuppressive Agents | 2 | 2017 | 673 | 0.130 |
Why?
|
| Hepatitis C | 1 | 2021 | 387 | 0.130 |
Why?
|
| Veterans Health | 1 | 2018 | 179 | 0.130 |
Why?
|
| Acetylcysteine | 2 | 2008 | 82 | 0.130 |
Why?
|
| Hepatitis C, Chronic | 1 | 2021 | 370 | 0.130 |
Why?
|
| Transplant Recipients | 1 | 2018 | 225 | 0.130 |
Why?
|
| Ileostomy | 1 | 2016 | 32 | 0.130 |
Why?
|
| Female | 15 | 2021 | 70787 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 7138 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 674 | 0.110 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 277 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2018 | 5176 | 0.110 |
Why?
|
| Proton Pump Inhibitors | 1 | 2016 | 282 | 0.100 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2013 | 7 | 0.100 |
Why?
|
| Pandemics | 1 | 2021 | 1186 | 0.100 |
Why?
|
| Hygiene | 1 | 2012 | 24 | 0.100 |
Why?
|
| Hospitals, Veterans | 2 | 2021 | 348 | 0.100 |
Why?
|
| Blood-Brain Barrier | 1 | 2013 | 156 | 0.090 |
Why?
|
| Registries | 1 | 2018 | 1591 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 223 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 630 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 926 | 0.080 |
Why?
|
| Staphylococcus epidermidis | 2 | 2007 | 40 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 742 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 5410 | 0.080 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2008 | 79 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1177 | 0.080 |
Why?
|
| Time Factors | 1 | 2018 | 6451 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2017 | 17395 | 0.070 |
Why?
|
| Young Adult | 2 | 2018 | 9966 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1966 | 0.070 |
Why?
|
| Equipment and Supplies | 1 | 2007 | 28 | 0.070 |
Why?
|
| Comorbidity | 2 | 2017 | 1610 | 0.070 |
Why?
|
| Gram-Positive Bacteria | 1 | 2007 | 48 | 0.070 |
Why?
|
| Gram-Negative Bacteria | 1 | 2007 | 73 | 0.060 |
Why?
|
| Pyelitis | 1 | 2006 | 2 | 0.060 |
Why?
|
| Staphylococcus aureus | 2 | 2007 | 479 | 0.060 |
Why?
|
| Urinary Calculi | 1 | 2006 | 19 | 0.060 |
Why?
|
| Michigan | 1 | 2006 | 50 | 0.060 |
Why?
|
| Enterococcus | 1 | 2006 | 31 | 0.060 |
Why?
|
| Plasma Cells | 1 | 2006 | 56 | 0.060 |
Why?
|
| Embolism | 1 | 2006 | 47 | 0.060 |
Why?
|
| Granuloma | 1 | 2006 | 66 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2006 | 150 | 0.060 |
Why?
|
| Remission Induction | 1 | 2006 | 306 | 0.060 |
Why?
|
| Risk Factors | 4 | 2017 | 10945 | 0.060 |
Why?
|
| Ureteral Obstruction | 1 | 2006 | 105 | 0.060 |
Why?
|
| Pancreatic Diseases | 1 | 2005 | 39 | 0.060 |
Why?
|
| HIV Infections | 1 | 2017 | 2049 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2166 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3139 | 0.050 |
Why?
|
| Kidney Function Tests | 1 | 2005 | 138 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 234 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2016 | 13027 | 0.050 |
Why?
|
| Outpatients | 1 | 2006 | 275 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2006 | 1233 | 0.050 |
Why?
|
| Escherichia coli Infections | 1 | 2006 | 192 | 0.050 |
Why?
|
| Mitral Valve | 1 | 2006 | 269 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2012 | 6568 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2005 | 209 | 0.050 |
Why?
|
| Adolescent | 2 | 2018 | 20557 | 0.050 |
Why?
|
| Creatinine | 1 | 2005 | 413 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2006 | 559 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2006 | 1574 | 0.050 |
Why?
|
| Recurrence | 1 | 2006 | 1453 | 0.050 |
Why?
|
| Logistic Models | 2 | 2016 | 1841 | 0.050 |
Why?
|
| Opportunistic Infections | 1 | 2002 | 80 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2002 | 126 | 0.040 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2006 | 462 | 0.040 |
Why?
|
| Length of Stay | 1 | 2007 | 1382 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 569 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1718 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2006 | 1081 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2005 | 671 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2005 | 490 | 0.040 |
Why?
|
| Allografts | 1 | 2021 | 196 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2021 | 272 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2005 | 1700 | 0.040 |
Why?
|
| Texas | 1 | 2007 | 3632 | 0.040 |
Why?
|
| Prevalence | 1 | 2005 | 2664 | 0.040 |
Why?
|
| Health Facilities | 1 | 2018 | 69 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 503 | 0.030 |
Why?
|
| Causality | 1 | 2017 | 94 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2005 | 861 | 0.030 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 56 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 3093 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2018 | 396 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 823 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 255 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2005 | 3736 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 1418 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 2017 | 347 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 1255 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1444 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2016 | 425 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 1461 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 697 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 1234 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3414 | 0.020 |
Why?
|
| Incidence | 1 | 2017 | 3376 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2008 | 91 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2007 | 280 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 140 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2006 | 650 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 1444 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2007 | 382 | 0.010 |
Why?
|
| Bacteria | 1 | 2007 | 522 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2002 | 321 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 796 | 0.010 |
Why?
|